tiprankstipranks
Rohto Pharmaceutical Co Ltd (RPHCF)
OTHER OTC:RPHCF
US Market

Rohto Pharmaceutical Co (RPHCF) Financial Statements

Compare
3 Followers

Rohto Pharmaceutical Co Financial Overview

Rohto Pharmaceutical Co's market cap is currently $3.56B. The company's EPS TTM is $0.851; its P/E ratio is 18.24; and it has a dividend yield of 1.34%. Rohto Pharmaceutical Co is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is $0.17. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue¥ 270.84B¥ 238.66B¥ 199.65B¥ 181.05B¥ 188.38B
Gross Profit¥ 157.29B¥ 137.42B¥ 116.49B¥ 106.73B¥ 114.24B
Operating Income¥ 40.05B¥ 33.96B¥ 29.35B¥ 22.99B¥ 23.09B
EBITDA¥ 50.40B¥ 41.34B¥ 35.81B¥ 28.61B¥ 29.82B
Net Income¥ 30.94B¥ 26.38B¥ 21.13B¥ 16.74B¥ 15.41B
Balance Sheet
Cash & Short-Term Investments¥ 89.21B¥ 79.95B¥ 72.79B¥ 52.96B¥ 45.31B
Total Assets¥ 346.18B¥ 309.68B¥ 274.63B¥ 225.79B¥ 215.30B
Total Debt¥ 10.49B¥ 11.69B¥ 21.38B¥ 8.10B¥ 7.29B
Net Debt¥ -78.72B¥ -68.26B¥ -51.41B¥ -44.87B¥ -38.01B
Total Liabilities¥ 99.14B¥ 94.60B¥ 90.80B¥ 69.18B¥ 75.27B
Stockholders' Equity¥ 246.32B¥ 209.57B¥ 178.28B¥ 155.91B¥ 139.28B
Cash Flow
Free Cash Flow¥ 25.33B¥ 21.02B¥ 15.92B¥ 9.70B¥ 12.61B
Operating Cash Flow¥ 34.24B¥ 30.92B¥ 27.25B¥ 20.01B¥ 19.04B
Investing Cash Flow¥ -16.32B¥ -13.18B¥ -16.41B¥ -10.24B¥ -9.40B
Financing Cash Flow¥ -13.78B¥ -16.20B¥ 3.47B¥ -2.35B¥ -1.60B
Currency in JPY

Rohto Pharmaceutical Co Earnings and Revenue History

Rohto Pharmaceutical Co Debt to Assets

Rohto Pharmaceutical Co Cash Flow

Rohto Pharmaceutical Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis